Literature DB >> 33754483

Combined use of emapalumab and ruxolitinib in a patient with refractory hemophagocytic lymphohistiocytosis was safe and effective.

Michael P Triebwasser1,2, David M Barrett1,2,3, Hamid Bassiri2,3,4, Nancy Bunin1,2,3, Caitlin Elgarten1,2,3, Jason Freedman1,2, Abdallah S Geera5, Dimitri Monos6,7, Michele P Lambert2,3,8, Timothy Olson1,2, Alix E Seif1,3, Michele Paessler3,6,7, Whitney Petrosa3, Anne F Reilly1,2,3, Neil Romberg2,3,9, Kathleen E Sullivan2,3,9, Ghazal Z Quinn5, Edward Behrens2,3,10, David T Teachey1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33754483      PMCID： PMC9269994          DOI： 10.1002/pbc.29026

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.838


× No keyword cloud information.
  6 in total

1.  IFN-gamma negatively modulates self-renewal of repopulating human hemopoietic stem cells.

Authors:  Liping Yang; Ingunn Dybedal; David Bryder; Lars Nilsson; Ewa Sitnicka; Yutaka Sasaki; Sten Eirik W Jacobsen
Journal:  J Immunol       Date:  2005-01-15       Impact factor: 5.422

2.  Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial.

Authors:  Asra Ahmed; Samuel A Merrill; Fares Alsawah; Paula Bockenstedt; Erica Campagnaro; Sumana Devata; Scott D Gitlin; Mark Kaminski; Alice Cusick; Tycel Phillips; Suman Sood; Moshe Talpaz; Albert Quiery; Philip S Boonstra; Ryan A Wilcox
Journal:  Lancet Haematol       Date:  2019-09-16       Impact factor: 18.959

3.  Ruxolitinib for refractory/relapsed hemophagocytic lymphohistiocytosis.

Authors:  Jingshi Wang; Yini Wang; Lin Wu; Xinkai Wang; Zhili Jin; Zhuo Gao; Zhao Wang
Journal:  Haematologica       Date:  2019-09-12       Impact factor: 9.941

4.  Role of interferon-γ in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation.

Authors:  Pietro Merli; Ignazio Caruana; Rita De Vito; Luisa Strocchio; Gerrit Weber; Francesca Del Bufalo; Vanessa Buatois; Paolo Montanari; Maria Giuseppina Cefalo; Angela Pitisci; Mattia Algeri; Federica Galaverna; Concetta Quintarelli; Valentina Cirillo; Daria Pagliara; Walter Ferlin; Maria Ballabio; Cristina De Min; Franco Locatelli
Journal:  Haematologica       Date:  2019-02-21       Impact factor: 9.941

5.  IFN-gamma mediates the rejection of haematopoietic stem cells in IFN-gammaR1-deficient hosts.

Authors:  Martin Rottman; Claire Soudais; Guillaume Vogt; Laurent Renia; Jean-François Emile; Hélène Decaluwe; Jean-Louis Gaillard; Jean-Laurent Casanova
Journal:  PLoS Med       Date:  2008-01-29       Impact factor: 11.069

6.  Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification.

Authors:  Aziz Bousfiha; Leila Jeddane; Capucine Picard; Waleed Al-Herz; Fatima Ailal; Talal Chatila; Charlotte Cunningham-Rundles; Amos Etzioni; Jose Luis Franco; Steven M Holland; Christoph Klein; Tomohiro Morio; Hans D Ochs; Eric Oksenhendler; Jennifer Puck; Troy R Torgerson; Jean-Laurent Casanova; Kathleen E Sullivan; Stuart G Tangye
Journal:  J Clin Immunol       Date:  2020-02-11       Impact factor: 8.317
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.